Profile: Calmare Therapeutics Inc (CTTC.PK)

CTTC.PK on OTC Markets Group

11:44am EDT
Price Change (% chg)

$0.00 (+0.50%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Search Stocks

Calmare Therapeutics Incorporated., formerly Competitive Technologies, Inc., incorporated on August 12, 1971, provides distribution, patent and technology transfer, sales and licensing services focusing on the needs of its customers. The Company develops relationships with universities, companies, inventors and patent or intellectual property holders to obtain the rights or a license to their intellectual property (technologies), or to their product. It also develops relationships with those who have a need or use for technologies or products. Its life science portfolio includes pharmaceuticals, biotechnologies, and medical devices. The Company earns revenue in two ways: retained royalties from licensing its clients and the Company’s own technologies to its customer licensees, and sales of finished products.

The Company’s services are beneficial to the inventor, manufacturer and distributor of the product. It earns revenue on a per-unit basis through product distribution agreements. The Company shares the revenue with the product inventor, and/or manufacturer. For some products, it acts as the distributor in specific geographic areas, again sharing the revenue with product inventor and/ or manufacturer.

The Company identifies and commercializes technologies in life and physical sciences, electronics, and nano science. Life sciences include medical testing, diagnostics, pharmaceuticals, biotechnologies, medical devices and other medical or biological applications. Physical sciences include chemical, display, and environmental applications. Electronics include communications, semiconductors, Internet related, e-commerce and consumer electronics applications.

The Company commercializes technologies and products through contacts in research and development, legal firms, corporations, seminars and trade shows. It determines the users of the technologies or distributors of products, and contact prospective customers. It license technologies to generate revenue based on usage or sales of the technologies, or by sharing in the profits of distribution.

Company Address

Calmare Therapeutics Inc

Suite 400, 1375 Kings Highway Ea
FAIRFIELD   CT   06824
P: +1203.3686044
F: +1203.3685399

Company Web Links

Search Stocks